A Validation Study of the International Consensus Diagnostic Criteria for Neuroleptic Malignant Syndrome

Journal of Clinical Psychopharmacology

Volumn 37, Issue 1, 2017, Pages 67-71

  Gurrera, Ronald J ^a,b   Mortillaro, Gino ^b,c   Velamoor, Varadaraj ^d   Caroff, Stanley N ^d  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

antipsychotics; catatonia; diagnosis; interrater agreement; neuroleptic malignant syndrome; validity

Indexed keywords

ARTICLE; CORRELATION ANALYSIS; CRITERION RELATED VALIDITY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DSM-IV-TR; HUMAN; INTERNATIONAL CONSENSUS DIAGNOSTIC CRITERIA; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TELECONSULTATION; VALIDATION STUDY; CLASSIFICATION; CONSENSUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; NEUROLOGIC EXAMINATION; STANDARDS;

CONSENSUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; SENSITIVITY AND SPECIFICITY;

EID: 85009731532     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000640     Document Type: Article

References (12)

1. Online database for researchers and medical professionals: trends (ICD-9 diagnosis code 333.92). Rockville, MD: Agency for Healthcare Research and Quality; 2016. Available at: http://hcupnet.ahrq.gov/. Accessed June 5, 2016.
2. Nakamura M, Yasunaga H, Miyata H, et al. Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese Diagnosis Procedure Combination Database. J Clin Psychiatry. 2012;73:427-430.
3. Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatry. 1980;41:79-83.
4. Gurrera RJ, Caroff SN, Cohen A, et al. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry. 2011;72:1222-1228.
5. Trollor JN, Chen X, Chitty K, et al. Comparison of neuroleptic malignant syndrome induced by first-and second-generation antipsychotics. Br J Psychiatry. 2012;201:52-56.
6. Hsiao JK, Bartko JJ, PotterWZ. Diagnosing diagnoses. Receiver operating characteristic methods and psychiatry. Arch Gen Psychiatry. 1989;46: 664-667.
7. Bewick V, Cheek L, Ball J. Statistics review 13: receiver operating characteristic curves. Crit Care. 2004;8:508-512.
8. Bartko JJ, Carpenter WT Jr. On the methods and theory of reliability. J NervMentDis. 1976;163:307-317.
9. Fleiss JL. The measurement of interrater agreement. In: Statistical Methods for Rates and Proportions. 2nd ed. New York: John Wiley & Sons; 1981:212-236.
10. Lang FU, Lang S, Becker T, et al. Neuroleptic malignant syndrome or catatonia Trying to solve the catatonic dilemma. Psychopharmacology (Berl). 2015;232:1-5.
11. Caroff SN, Mann SC, Campbell EC. Neuroleptic malignant syndrome and the catatonic dilemma. Psychopharmacology (Berl). 2015;232:661-662.
12. Loeb E, Madigand J, Alexandre J, et al. Neuroleptic malignant syndrome and catatonia overlapping: 2 case reports. Psychopharmacology (Berl). 2015;232:2643-4.